or Try an Advanced Search...

    Technical Analysis for RPTX - Repare Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 3.33 0.91% 0.03
    RPTX closed up 0.91 percent on Monday, July 1, 2024, on 24 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical RPTX trend table...
    Date Alert Name Type % Chg
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 0.91%
    Inside Day Range Contraction 0.91%
    Oversold Stochastic Weakness 0.91%
    50 DMA Resistance Bearish -1.48%
    Bullish Engulfing Bullish -1.48%
    Doji - Bullish? Reversal -1.48%
    Oversold Stochastic Weakness -1.48%
    Doji - Bullish? Reversal -1.19%
    Oversold Stochastic Weakness -1.19%
    Older End-of-Day Signals for RPTX ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 6 hours ago
    Down 1% about 6 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Up 3% about 10 hours ago
    Up 2% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RPTX Chart by TradingView
    Basic chart:

    Profile

    Repare Therapeutics is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Genetics Precision Medicine Cancer Therapies Genome CRISPR Synthetic Lethality

    Is RPTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 26 Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI
    Jun 10 Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial
    Jun 6 Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
    Jun 4 Repare gets FDA fast track status for ovarian cancer drug combo
    Jun 4 Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer
    Jun 3 Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 29 Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024
    May 12 Need To Know: Analysts Are Much More Bullish On Repare Therapeutics Inc. (NASDAQ:RPTX)
    May 9 Repare Therapeutics First Quarter 2024 Earnings: Beats Expectations
    May 7 Repare Therapeutics GAAP EPS of $0.30 beats by $0.32, revenue of $52.4M beats by $14M
    See more RPTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.85
    52 Week Low 2.98
    Average Volume 285,839
    200-Day Moving Average 5.58
    50-Day Moving Average 3.49
    20-Day Moving Average 3.66
    10-Day Moving Average 3.48
    Average True Range 0.25
    RSI (14) 40.12
    ADX 13.57
    +DI 18.57
    -DI 20.77
    Chandelier Exit (Long, 3 ATRs) 3.39
    Chandelier Exit (Short, 3 ATRs) 3.94
    Upper Bollinger Bands 4.15
    Lower Bollinger Band 3.18
    Percent B (%b) 0.16
    BandWidth 26.56
    MACD Line -0.07
    MACD Signal Line -0.02
    MACD Histogram -0.0514
    Fundamentals Value
    Market Cap 140.29 Million
    Num Shares 42.1 Million
    EPS -2.31
    Price-to-Earnings (P/E) Ratio -1.44
    Price-to-Sales 6.17
    Price-to-Book 1.40
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.56
    Resistance 3 (R3) 3.56 3.48 3.52
    Resistance 2 (R2) 3.48 3.42 3.48 3.51
    Resistance 1 (R1) 3.41 3.38 3.44 3.41 3.50
    Pivot Point 3.33 3.33 3.34 3.33 3.33
    Support 1 (S1) 3.25 3.27 3.29 3.25 3.16
    Support 2 (S2) 3.17 3.23 3.17 3.15
    Support 3 (S3) 3.10 3.17 3.14
    Support 4 (S4) 3.10